CLINICAL_TRIALS
trial_result
· 2010-07-08
Clinical Trial Update: Stem Cell Mobilization With Pegfilgrastim in Lymphoma and Myeloma [Phase 2]
Summary
A Phase 2 clinical trial evaluating pegfilgrastim for stem cell mobilization in lymphoma and multiple myeloma has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Centre Leon Berard | Conditions: Lymphoma, Myeloma | Phase 2 | Status: COMPLETED